Abstract:Myeloid-derived suppressor cells (MDSCs) are a hetero geneous group of cells, which can suppress the immune response, promote tumor progression and impair the efficacy of immunotherapies. Consequently, the pharmacological targeting of MDSC is emerging as a new immunotherapeutic strategy to stimulate the natural anti-tumor immune response and potentiate the efficacy of immunotherapies. Herein, we leveraged genetically modified models and a small molecule inhibitor to validate Calcium-Calmodulin Kinase Kinase 2 (CaMKK2) as a druggable target to control MDSC accumulation in tumor-bearing mice. The results indicated that deletion of CaMKK2 in the host attenuated the growth of engrafted tumor cells, and this phenomenon was associated with increased antitumor T cell response and decreased accumulation of MDSC. The adoptive transfer of MDSC was sufficient to restore the ability of the tumor to grow in Camkk2 -/- mice, confirming the key role of MDSC in the mechanism of tumor rejection. In vitro studies indicated that blocking of CaMKK2 is sufficient to impair the yield of MDSC. Surprisingly, MDSC generated from Camkk2 -/- bone marrow cells also showed a higher ability to terminally differentiate toward more immunogenic cell types (e.g inflammatory macrophages and dendritic cells) compared to wild type (WT). Higher intracellular levels of reactive oxygen species (ROS) accumulated in Camkk2 -/- MDSC, increasing their susceptibility to apoptosis and promoting their terminal differentiation toward more mature myeloid cells. Mechanistic studies indicated that AMP-activated protein kinase (AMPK), which is a known CaMKK2 proximal target controlling the oxidative stress response, fine-tunes ROS accumulation in MDSC. Accordingly, failure to activate the CaMKK2-AMPK axis can account for the elevated ROS levels in Camkk2 -/- MDSC. These results highlight CaMKK2 as an important regulator of the MDSC lifecycle, identifying this kinase as a new druggable target to restrain MDSC expansion and enhance the efficacy of anti-tumor immunotherapy.

Akt2 is required for macrophage chemotaxis.

Pivotal Advance: PKCzeta is required for migration of macrophages.

Reduction of Akt2 expression inhibits chemotaxis signal transduction in human breast cancer cells

Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling

Remodeling Tumor-Associated Macrophage for Anti-Cancer Effects by Rational Design of Irreversible Inhibition of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2

Down-Regulation Of Pkc Zeta Expression Inhibits Chemotaxis Signal Transduction In Human Lung Cancer Cells

Tumor Progression Locus 2 (tpl2) Kinase Promotes Chemokine Receptor Expression and Macrophage Migration During Acute Inflammation

Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization

CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation

Protein Kinase C ζ Is Required for Epidermal Growth Factor–Induced Chemotaxis of Human Breast Cancer Cells

Protein Kinase C Zeta is Required for Epidermal Growth Factor-Induced Chemotaxis of Human Breast Cancer Cells.

Akt-Mtorc1 Signaling Regulates Acly To Integrate Metabolic Input To Control Of Macrophage Activation

Akt2 Affects Periodontal Inflammation Via Altering the M1/M2 Ratio.

Akt1-mediated Regulation of Macrophage Polarization in a Murine Model of Staphylococcus Aureus Pulmonary Infection.

Macrophage-Induced Tumor Angiogenesis is Regulated by the Tsc2-Mtor Pathway.

M-CSF cooperating with NFκB induces macrophage transformation from M1 to M2 by upregulating c-Jun

Cellular signaling in macrophage migration and chemotaxis

Calcium/Calmodulin Dependent Protein Kinase Kinase 2 Regulates the Expansion of Tumor-Induced Myeloid-Derived Suppressor Cells

AK2 Promotes the Migration and Invasion of Lung Adenocarcinoma by Activating TGF-β/Smad Pathway in Vitro and in Vivo

Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization

Quantitative Study of the Interactome of PKCζ Involved in the EGF-induced Tumor Cell Chemotaxis.